Skip to main content

Table 3 Bivariate and multivariate associations between mother-infant pairs' non adherence to medication at birth and potential determinants

From: Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study

Variable

Mother-infant pairs ingested

medication at birth

Unadjusted

OR (95% CI)

Adjusted

OR (95% CI)

 

Yes

n(%)

No

n(%)

  

Age in years

    

   15-24

48(63.2)

28(36.8)

1

 

   25-29

60(69.8)

26(30.2)

1.35(0.64-2.85)

 

   ≥ 30

37(69.8)

16(30.2)

1.0(0.48-2.11)

 

Education (grade completed)

    

   0-4

38(62.3)

23(37.7)

1

 

   5-8

55(70.5)

23(29.5)

0.69(0.34-1.41)

 

   ≥9

54(73.0)

20(27.0)

0.61(0.30-1.27)

 

Number of pregnancies

    

   First

48(69.6)

21(30.4)

1

1

   Second

59(73.8)

21(26.3)

0.81(0.40-1.66)

0.60(0.27-1.34)

   Three or more

39(58.2)

28(41.8)

1.64(0.81-3.32)

1.34(0.62-2.87)

Gestational age at enrolment

    

   < 28 weeks

78(64.5)

43(35.5)

1

 

   ≥ 28 weeks

47(71.2)

19(28.8)

0.7(0.38-1.40)

 

CD4 cell count/mm 3

    

   ≥ 350

49(75.4)

16(24.6)

1

 

   200-349

31(67.4)

15(32.6)

2.08(0.90-4.80)

 

   < 200

25(59.5)

17(40.5)

1.48(0.64-3.42)

 

Disclosed to partner

    

   Yes

110(71.9)

43(28.1)

1

 

   No

19(63.3)

11(36.7)

1.48(0.65-3.37)

 

Medication initiated

    

   ZDV prophylaxis

101(74.8)

34(25.2)

1

1

   Lifelong ART

45(63.4)

26(36.6)

1.72(.92-3.19)

1.85(0.96-3.56)

Place of delivery

    

   Health facility

143(70.8)

59(29.2)

1

1

   Home

5(29.4)

12(70.6)

5.82(1.96-17.24)

6.72(2.90-21.65)

  1. Due to missing values, the numbers may not add up to the total